Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ponde, D. E."'
Autor:
Bisogno, T., Hanuš, L., Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., Vincenzo Di Marzo
Publikováno v:
Scopus-Elsevier
British journal of pharmacology 134 (2001): 845–852. doi:10.1038/sj.bjp.0704327
info:cnr-pdr/source/autori:Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D., Brandi I., Schiano Moriello A., Davis J.B., Mechoulam R. and Di Marzo V./titolo:Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide/doi:10.1038%2Fsj.bjp.0704327/rivista:British journal of pharmacology/anno:2001/pagina_da:845/pagina_a:852/intervallo_pagine:845–852/volume:134
British journal of pharmacology 134 (2001): 845–852. doi:10.1038/sj.bjp.0704327
info:cnr-pdr/source/autori:Bisogno T., Hanus L., De Petrocellis L., Tchilibon S., Ponde D., Brandi I., Schiano Moriello A., Davis J.B., Mechoulam R. and Di Marzo V./titolo:Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide/doi:10.1038%2Fsj.bjp.0704327/rivista:British journal of pharmacology/anno:2001/pagina_da:845/pagina_a:852/intervallo_pagine:845–852/volume:134
1. (-)-Cannabidiol (CBD) is a non-psychotropic component of Cannabis with possible therapeutic use as an anti-inflammatory drug. Little is known on the possible molecular targets of this compound. We investigated whether CBD and some of its derivativ
Publikováno v:
Organic Process Research & Development; November 2000, Vol. 4 Issue: 6 p509-512, 4p
Autor:
Ponde, D. E., Wang, L.
Publikováno v:
Indian Journal of Nuclear Medicine; Oct-Dec2007, Vol. 22 Issue 4, p113-114, 2p
Publikováno v:
ChemInform; Jun1998, Vol. 29 Issue 25, pno-no, 1p
Publikováno v:
Journal of Chromatography A; 1994, Vol. 662 Issue: 2 p420-420, 1p